[Effect of therapy with clopidogrel on walking tolerance and parameters of hemostasis in patients with atherosclerosis of lower extremities and intermittent claudication].
Komarov
A L
AL
Kropacheva
E S
ES
Tarasova
T N
TN
Dobrovol'skiĭ
A B
AB
Titaeva
E V
EV
Mironova
I Yu
IY
Naumov
V G
VG
Panchenko
E P
EP
D000368:Aged; D001161:Arteriosclerosis / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D000077144:Clopidogrel; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D035002:Lower Extremity / Q000098:blood supply* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology*; D010807:Physical Endurance / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use*; D016138:Walking / Q000502:physiology
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine